Moreover, it showed that germline PALB2 mutations were rare; PALB2 mutation carriers were found in only 0.21% of the ovarian cancer patients analysed, which is not significantly different from the frequency in the general population (0.05%) [84]. The gene discussed is PALB2; the disease is ovarian carcinoma.